Spectranetics (SPNC) PT Raised to $42 at Piper Jaffray as Newly Acquired Stellarex DCB Launches At LINC
Tweet Send to a Friend
Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Spectranetics (NASDAQ: SPNC) to $42.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
